Development of a Quasi-Dynamic Pharmacophore Model for Anti-Complement Peptide Analogues

Buddhadeb Mallik and Dimitrios Morikis*
Contribution from the Department of Chemical and Environmental Engineering, University of California at Riverside, Riverside, California 92521
J. Am. Chem. Soc., 2005, 127 (31), pp 10967–10976
DOI: 10.1021/ja051004c
Publication Date (Web): July 15, 2005
Copyright © 2005 American Chemical Society

Abstract

Abstract Image

Three quasi-dynamic pharmacophore models have been constructed for the complement inhibitor peptide compstatin, using first principles. Uniform sampling along 5-ns molecular dynamics trajectories provided dynamic conformers that are thought to represent the entire conformational space for nine training set molecules, compstatin, four active analogues, and four inactive analogues. The pharmacophore models were built using mixed physicochemical and structural properties of residues indispensable for structural stability and activity. Owing to the size and flexibility of compstatin, one-dimensional probability distributions of intrapharmacophore point distances, angles, and dihedral angles of different analogues spread over wide and overlapping ranges. More robust two-dimensional distance−angle probability distributions for two pharmacophore models discriminated individual analogues in terms of specific distance−angle pairs, but overall failed to identify the active and the inactive analogues as two distinct groups. Two-dimensional distance−dihedral angle probability distributions in a third pharmacophore model allowed discrimination of the groups of active and inactive analogues more effectively, with the highest-activity analogue having distinct behavior. The present study indicates that more stringent structural constraints should be used for a set of structurally similar but flexible peptides, as opposed to organic molecules, to convert dynamic conformers into pharmacophore models. Flexibility is a general aspect of the structure and function of peptides and should be taken into account in ligand-based pharmacophore design. However, the discrimination of activity using multidimensional probability surfaces depends on the peptide system, the selection of the training set, the molecular dynamics protocol, and the selection of the type and number of pharmacophore points.

Available Supporting Information for This Article

PDF

 

Electronic Supporting Information files are available without a subscription to ACS Web Editions. All files are copyrighted by the American Chemical Society. Files may be downloaded for personal use only. Users are not permitted to reproduce, republish, redistribute, or resell any Supporting Information, either in whole or in part, in either machine-readable form or any other form without permission from the American Chemical Society. For permission to reproduce this material, requesters must process their own requests via the Rightslink permission system. Information about how to use the Rightslink permission system can be found at http://pubs.acs.org/page/copyright/permissions.html. Please read only the part about Rightslink.

Tools

SciFinder Links

SciFinder subscribers:  Click to sign in | Not a SciFinder subscriber? Learn more at www.cas.org

Explore by:


History

  • Published In Issue August 10, 2005
  • Received February 16, 2005

Recommend & Share

Related Content

Other ACS content by these authors: